Increase in AP-1 transcription factor DNA binding activity by valproic acid

Neuropsychopharmacology

Volumn 16, Issue 3, 1997, Pages 238-245

  Chen, Guang ^a   Yuan, Peixiong ^a   Hawver, David B ^c   Potter, William Z ^c   Manji, Husseini K ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

anticon vulsant; AP 1; bipolar affective disorder; c fos; c jun; CREB; depression; lithium; mania; transcription factors; valproic acid

Indexed keywords

CYCLOHEXIMIDE; VALPROIC ACID;

ANIMAL CELL; ARTICLE; DNA BINDING; GENETIC TRANSCRIPTION; GLIOMA CELL; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0031105918     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00239-4     Document Type: Article

References (25)

1. Bourgeois BFD (1989): Valproate: Clinical Use. In Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds), Antiepileptic, ed 3, New York, Raven, pp 633-641
2. Bowden CL, Brugger AM, Swenn AA, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG (1994): Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271:918-924
3. Bullock BP, McNeil GP, Dobner PR (1994): Synergistic induction of neurotensin gene transcription in PC 12 cells parallels changes in AP-1 activity. Brain Res Mol Brain Res 27:232-242
4. Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ (1994a): Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 63:2361-2364
5. Chen G, Manji HK, Hawver DB, Potter WZ (1994b) Selective decreases of PKC isozymes and PKC substrates by the anticonvulsant and antimanic agent valproic acid in vitro (Abstract). Annual meeting of Society for Neuroscience meeting. Miami Beach. November 1994
6. Cohen P, Alemany S, Hemmings BA, Resink TJ, Stralfors P, Tung HY (1988): Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol 159:390-408
7. Cohen P, Klumpp S, Schelling DL (1989): An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 250:596-600
8. Jackson S (1992): Regulating transcription factor activity by phosphorylation. Trends Cell Biol 2:104-108
9. Kalasapudi VD, Sheftel G, Divish MM, Papolos DF, Lachman HM (1990): Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium. Brain Res 521:47-54
10. Karin M, Smeal T (1992): Control of transcription factors by signal transduction pathways: The beginning of the end. TIBS 17:418-422
11. Korhauser JM, Nelson De, Mayo KE, Takahashi J (1992): regulation of jun-B messenger and AP-1 activity by light and a circadian clock. Science 255:1581-1584
12. Kuntz-Simon G, Orbert G (1995): Sodium valproate, an anti-convulsant drug, stimulates human cytomegalovirus replication. J Gen Virol 76:1409-1415
13. 2A receptor-mediated c-fos expression in rat cerebral cortex. Neuroreport 5:241-244
14. Löscher W. (1993): Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochemical Res 18:485-502
15. Manji HK, Lenox RH. (1994): Long-term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16:11-28
16. Manji HK, Potter WZ, Lenox RH (1995): Signal transduction pathways: molecular targets for lithium's actions. Archives of General Psychiatry 52:531-543
17. McElroy SL, Keck J, Pope J, Hudson JI (1992): Valproate in the treatment of bipolar disorder: Literature review and clinical/guideline. J Clin Psychopharmacol 12:42S-52S
18. Post RM, Weiss SR, Chaung DM (1992): Mechanisms of action of anticonvulsants in affective disorders: Comparisons with lithium. J Clin Psychopharmacol 12:23S-35S
19. Promega protocols and applications guide. Madison, WI, Promega, 1991
20. Rogawski MA, Porter RJ (1990): Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising development stage compounds. Pharmacol Rev 42:223-286
21. Sheng M, Greenberg ME (1990): The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4:477-485
22. Simon G, Moog C, Obert G (1994): Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus. Chem Biol Interact 91:111-121
23. Weiner ED, Kalasapudi VD, Papolos DF, Lachman HM (1991): Lithium augments pilocarpine-induced fos gene expression in rat brain. Brain Res 553:117-122
24. Williams MB, Jope RS (1994): Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Brain Res Mol Brain Res 25:80-89
25. Woodgett JR, Pulverer BJ, Nikolakaki E, Plyte S, Hughes K, Franklin CC, Kraft AS (1993): Regulation of jun/AP-1 oncoproteins by protein phosphorylation. Adv Second Messenger Phosphoprotein Res 28:261-269